NewsMeter

Sanuwave Health Q2 2026: $9.7M Revenue, Adjusted EBITDA Falls 62% as System Sales Slide

8/7/2026

$9.7 million in Q2 2026 revenue at Sanuwave Health (NASDAQ: SNWV) came in 3% below the prior-year $10.1 million, per the company's August 6, 2026 8-K filing.

Ultramist applicator revenue of $7.3 million accounted for approximately 75% of that total; system sales absorbed the balance.

Adjusted EBITDA fell 62% year-over-year to $1.2 million from $3.2 million, and GAAP operating income swung to a $(0.3) million loss from a $1.4 million gain.

Applicator volume and system unit counts diverge Applicator momentum and system volumes ran in opposite directions.